- Home
- BWIN
as 01-17-2025 4:00pm EST
The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | TAMPA |
| Market Cap: | 3.1B | IPO Year: | 2019 |
| Target Price: | $44.80 | AVG Volume (30 days): | 536.9K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $21.70 - $55.82 | Next Earning Date: | 02-25-2025 |
| Revenue: | $1,343,793,000 | Revenue Growth: | 13.89% |
| Revenue Growth (this year): | 15.96% | Revenue Growth (next year): | 13.09% |
Latest The Baldwin Insurance Group Inc. Class A Common Stock News
BWIN Breaking Stock News: Dive into BWIN Ticker-Specific Updates for Smart Investing
Business Wire
4 days ago
The Baldwin Group to Report Fourth Quarter 2024 Results on Tuesday, February 25, 2025
Business Wire
a month ago
The Baldwin Group Announces (I) Successful Repricing for $837.9 Million Term Loan Facility and (II) Pricing of $100 Million Incremental Term Loan B Add-On
Simply Wall St.
2 months ago
Baldwin Insurance Group Third Quarter 2024 Earnings: Misses Expectations
TipRanks
2 months ago
Baldwin Group price target lowered to $43 from $46 at Wells Fargo
Business Wire
2 months ago
The Baldwin Group Announces Third Quarter 2024 Results
Investor's Business Daily
3 months ago
These IBD 50 Leaders Melt Gains As Stock Market Wavers
GuruFocus.com
3 months ago
The Baldwin Insurance Group Inc (BWIN) Q3 2024: Everything You Need to Know Ahead of Earnings
Investor's Business Daily
3 months ago
Payments Firm Trounces Nvidia On This Elite List With Whopping 967% Gain
Compare BWIN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BWIN The Baldwin Insurance Group Inc. Class A Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.